Boston Scientific Corporation

NYSE:BSX

Medical - Devices

Healthcare
$43.64 +1.00%

+$0.45 today

Market cap
$63.25B
Beta
0.56
P/E (TTM)
19.0
EPS (TTM)
$2.39
52W Low $44.44High $109.50

Volume 13.21M

Average 19.45M

BSX Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Boston Scientific CorporationNYSE: BSX

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 70.7%

Gross margin was 70.7% in Q2 FY2026, up 3.1 pp from a year earlier. On a trailing-twelve-month basis it was 71.2%, up 7.9 pp year over year. Over 3 fiscal years it widened by 8.2 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
70.7%+1.3 pp QoQ
Last fiscal yearDec 2025
69.0%+7.7 pp YoY
LTMJun 2026
71.2%+7.9 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+3.1 pp——
1 year+7.7 pp——
3 years+8.2 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
69.0%
Year-over-year change
+7.7pp

Gross Margin vs competitors

How BSX compares with its peers on the latest reported figures

  • BSX's LTM Jun 2026 gross margin of 71.2% is the 4th highest of the 11 companies compared; the peer median is 67.3%.
  • Its year-over-year change of +7.9 pp is the highest of 11, against a peer median of +0.2 pp.
  • Over three fiscal years its change of +8.2 pp compares with a peer median of +0.7 pp.
BSX Competitors Peer median
Gross Margin for BSX and competitors
Company Period LTM level YoY 3-year change
CVRXCVRx, Inc.LTM Mar 202685.5% +1.8 pp+7.6 pp
EWEdwards Lifesciences CorporationLTM Jun 202678.0% -0.9 pp-0.2 pp
ATRCAtriCure, Inc.LTM Jun 202676.2% +1.5 pp-0.0 pp
BSXBoston Scientific CorporationLTM Jun 202671.2% +7.9 pp+8.2 pp
LIVNLivaNova PLCLTM Sep 202667.9% -0.6 pp-1.5 pp
PENPenumbra, Inc.LTM Jun 202667.8% +1.4 pp+4.0 pp
MDTMedtronic plcLTM Jul 202666.7% +3.3 pp-0.7 pp
TFXTeleflex IncorporatedLTM Jun 202653.8% -1.8 pp+1.4 pp
CNMDCONMED CorporationLTM Mar 202653.6% -1.9 pp-1.9 pp
ANGOAngioDynamics, Inc.LTM Feb 202653.5% -0.9 pp+1.5 pp
MMSIMerit Medical Systems, Inc.LTM Sep 202649.4% +0.9 pp+3.6 pp
Peer median (excluding BSX) 67.3%+0.2 pp+0.7 pp

Competitors are the stored peer set for BSX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue11.89B12.68B14.24B16.75B20.07B
Cost of Revenue4.43B4.97B5.41B6.48B6.22B
Gross Profit7.46B7.71B8.83B10.27B13.85B
Gross Margin62.8%60.8%62.0%61.3%69.0%
Research & Development1.2B1.32B1.41B1.62B2.05B
Selling, General & Admin4.29B4.52B5.19B5.98B6.89B
Operating Expenses5.54B5.89B6.65B7.63B9.88B
Depreciation & Amortization1.09B1.14B1.2B1.27B1.37B
EBITDA2.52B2.74B3.45B3.94B5.1B
EBITDA Margin21.2%21.6%24.2%23.5%25.4%
Operating Income1.92B1.82B2.18B2.64B3.97B
Operating Margin16.2%14.4%15.3%15.7%19.8%
Interest Income4M10M22M107M0
Interest Expense349M464M272M387M349M
Other Income / Expenses(846M)(683M)(196M)(353M)(586M)
Income Before Tax1.08B1.14B1.99B2.28B3.39B
Pre-Tax Margin9.1%9.0%13.9%13.6%16.9%
Income Tax Expense36M443M393M436M493M
Net Income1.04B698M1.59B1.85B2.89B
Net Margin8.7%5.5%11.2%11.1%14.4%
EPS (Basic)0.690.451.081.261.96
EPS (Diluted)0.690.451.071.251.94
Weighted Avg Shares1.42B1.43B1.45B1.47B1.48B
Weighted Avg Shares (Diluted)1.43B1.44B1.46B1.49B1.49B

Boston Scientific Corporation

NYSE:BSX

Intrinsic Alpha fair value

Locked

Current Price

$43.64

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.